Investor profile
Invus has backed 17 European tech companies across 23 funding rounds between 2009 and 2025, joining rounds totalling €1.1B. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Also recorded as: Invus fund
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Artios | UK | 2 | €229M |
| Noema Pharma | Switzerland | 2 | €134M |
| Hemab Therapeutics | Denmark | 1 | €127M |
| Leyden Labs | Netherlands | 1 | €124M |
| Imcheck Therapeutics | France |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Artios | Series C | €130M | 2021-07 |
| Hemab Therapeutics | Series B | €127M | 2023-02 |
| Leyden Labs | Series B | €124M | 2022-01 |
| Noema Pharma |
| 1 |
| €96M |
| Agomab Therapeutics | Belgium | 1 | €83M |
| KNIME | Switzerland | 3 | €67M |
| Bizagi | UK | 1 | €40M |
| Future Finance | Ireland | 1 | €40M |
| FlatFrog Laboratories | Sweden | 3 | €40M |
| inotrem | France | 1 | €39M |
| Coave Therapeutics | France | 1 | €32M |
| One Biosciences | France | 1 | €15M |
| ZenRobotics | Finland | 1 | €13M |
| aive | France | 1 | €12M |
| The Curious AI | Finland | 1 | €3.1M |
| The curious AI company | Finland | 1 | €800k |
| Series B |
| €105M |
| 2023-03 |
| Artios | Series D+ | €99M | 2025-11 |
| Imcheck Therapeutics | Other | €96M | 2022-06 |
| Agomab Therapeutics | Series D+ | €83M | 2024-10 |
| Bizagi | Other | €40M | 2017-09 |
| Future Finance | Series C | €40M | 2018-01 |
| inotrem | Series B | €39M | 2019-10 |
